摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(苄氧基)甲基]苯胺 | 881741-06-6

中文名称
4-[(苄氧基)甲基]苯胺
中文别名
——
英文名称
4-(benzyloxymethyl)aniline
英文别名
4-benzyloxymethylphenylamine;benzyl 4-aminobenzyl ether;4-[(Benzyloxy)methyl]aniline;4-(phenylmethoxymethyl)aniline
4-[(苄氧基)甲基]苯胺化学式
CAS
881741-06-6
化学式
C14H15NO
mdl
——
分子量
213.279
InChiKey
FRISHJFEBJVKFQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.3±22.0 °C(Predicted)
  • 密度:
    1.113±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[(苄氧基)甲基]苯胺N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 lithium hydroxide 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 22.17h, 生成 5-(3-((4-((benzyloxy)methyl)phenyl)carbamoyl)phenyl)-2-methylnicotinic acid
    参考文献:
    名称:
    WO2024147009A1
    摘要:
    公开号:
  • 作为产物:
    描述:
    1-(苄氧基甲基)-4-硝基苯platinum(IV) oxide 氢气 作用下, 以 various solvent(s) 为溶剂, 反应 9.0h, 以92%的产率得到4-[(苄氧基)甲基]苯胺
    参考文献:
    名称:
    Poly(ethylene Glycol) (400) as Superior Solvent Medium against Ionic Liquids for Catalytic Hydrogenations with PtO2
    摘要:
    Adams' catalyst in poly(ethylene glycol) (PEG) (400) has been found to be a superior solvent over the ionic liquids by severalfold in promoting the hydrogenation of various functional groups. Both the catalyst and PEG were recycled efficiently over 10 runs without loss of activity, and substrate cross contamination was not observed despite a change in the substrate four times.
    DOI:
    10.1021/jo052604x
点击查看最新优质反应信息

文献信息

  • A P,N-Ligand for Palladium-Catalyzed Ammonia Arylation: Coupling of Deactivated Aryl Chlorides, Chemoselective Arylations, and Room Temperature Reactions
    作者:Rylan J. Lundgren、Brendan D. Peters、Pamela G. Alsabeh、Mark Stradiotto
    DOI:10.1002/anie.201000526
    日期:2010.6.1
    Amazing ammonia: A new air‐stable P,Nligand (Mor‐DalPhos) is reported that enables the palladium‐catalyzed cross‐coupling of ammonia to a variety of aryl chloride and aryl tosylate substrates with high chemoselectivity and, for the first time, at room temperature (see scheme; Ad=adamantyl, Ts=para‐toluenesulfonyl).
    惊人的气:据报道,一种新型的空气稳定的P,N-配体(Mor-DalPhos)使催化的气与多种具有高化学选择性的芳基和甲苯磺酸芳基酯的交叉偶联成为首次。 ,在室温下(参见方案; Ad =金刚烷基,Ts =对甲苯磺酰基)。
  • An Examination of the Palladium/Mor-DalPhos Catalyst System in the Context of Selective Ammonia Monoarylation at Room Temperature
    作者:Pamela G. Alsabeh、Rylan J. Lundgren、Robert McDonald、Carin C. C. Johansson Seechurn、Thomas J. Colacot、Mark Stradiotto
    DOI:10.1002/chem.201203640
    日期:2013.2.4
    (Mor‐DalPhos=di(1‐adamantyl)‐2‐morpholinophenylphosphine) catalyst system in Buchwald–Hartwig aminations employing ammonia was conducted to better understand the catalyst formation process and to guide the development of precatalysts for otherwise challenging room‐temperature ammonia monoarylations. The combination of [Pd(cinnamyl)Cl}2] and Mor‐DalPhos afforded [(κ2‐P,N‐Mor‐DalPhos)Pd(η1‐cinnamyl)Cl] (2)
    在使用的布赫瓦尔德-哈特维格胺胺化反应中,对[Pd(肉桂基)Cl} 2 ] / MOr-DalPhos(MOr-DalPhos =二(1-金刚烷基)-2-吗啉代苯基膦)催化剂体系进行了检查,以更好地理解该催化剂形成过程,并指导用于挑战室温单芳基化的预催化剂的开发。[的Pd(肉桂基)}的组合2 ]时,可以得到莫尔- DalPhos [(κ 2 - P,N -MOR-DalPhos)的Pd(η 1 -cinnamyl)CL](2),其在存在碱和氯苯,生成[(κ 2 - P,ñ -MOR-DalPhos)的Pd(PH)CL](1一)。从卤化物抽象1,得到[(κ 3 - P,N,O -MOR-DalPhos)的Pd(PH)]光学传递函数(5),带来的是由莫尔- DalPhos提供光的电位稳定的相互作用。的检查[(κ 2 - P,Ñ -MOR-DalPhos)的Pd(芳基)](图1b -
  • COMPOUNDS FOR CANCER CHEMOTHERAPEUTIC SENSITIZATION
    申请人:Regents of the University of Minnesota
    公开号:US20190240244A1
    公开(公告)日:2019-08-08
    The invention provides a compound of formula (I), (II) or (III): wherein R 1 , R 2 , R 3 , R 4 and R 5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.
    本发明提供了一种公式(I)、(II)或(III)的化合物: 其中R1、R2、R3、R4和R5具有说明书中描述的任何值,以及包含公式(I)、(II)或(III)的化合物的组合物。这些化合物和组合物作为化学治疗增敏剂是有用的。
  • Compounds for cancer chemotherapeutic sensitization
    申请人:Regents of the University of Minnesota
    公开号:US10617706B2
    公开(公告)日:2020-04-14
    The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.
    本发明提供了一种式 (I)、(II) 或 (III) 的化合物: 其中 R1、R2、R3、R4 和 R5 具有说明书中描述的任一数值,以及包含式 (I)、(II) 或 (III) 化合物的组合物。这些化合物和组合物可用作化疗增敏剂。
  • Chemoselective hydrogenation of nitrobenzyl ethers to aminobenzyl ethers catalyzed by palladium–nickel bimetallic nanoparticles
    作者:Wenwen Chen、Hailin Bao、Dingsheng Wang、Xinyan Wang、Yadong Li、Yuefei Hu
    DOI:10.1016/j.tet.2015.10.037
    日期:2015.12
    A highly efficient and chemoselective hydrogenation of nitrobenzyl ethers to aminobenzyl ethers was developed by using a novel palladium nickel bimetallic nanocatalyst. Since the catalytic selectivity was resulted from the synergistic effects between two metals rather than the traditional catalyst poisons, the hydrogenation proceeded smoothly under additive-free conditions. Thus, the work-up procedure was as simple as to recover the catalyst by a magnetic separation and then to evaporate the solvent. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫